Skip to main content
logo
Neuphoria Therapeutics Inc. (NEUP)
NASDAQ: NEUP · Real-Time Price · USD
3.820
-0.080 (-2.05%)
Aug 7, 2026, 4:00 PM EDT - Market closed

Neuphoria Therapeutics Financials Overview

Millions USD. Fiscal year is Jul - Jun.

Revenue & Profits
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Jun '25 Jun '24 Jun '23 Jun '22 Jun '21
Revenue
-0.0115.65----
Revenue Growth
------
Gross Profit
-0.0115.65----
Operating Income
-16.76-1.13-17.89-21.9811.044.32
Net Income
-17.43-0.37-15.49-21.38-15.01-6.52
Earnings Per Share
-11.06-0.23-18.62-43.20-29.79-16.19
EPS Growth
------

Cash & Debt
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Jun '25 Jun '24 Jun '23 Jun '22 Jun '21
Cash & Investments
19.4414.2112.6112.123.1521.37
Total Debt
00.120.240.350.480.65
Net Cash (Debt)
19.4414.0912.3711.7522.6720.72
Net Cash Growth
15.01%13.95%5.27%-48.18%9.43%693.39%
Net Cash Per Share
5.528.6814.8617.2836.1857.37

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Jun '25 Jun '24 Jun '23 Jun '22 Jun '21
Operating Cash Flow
-17.150.08-14.68-14.22-15.01-5.65
Capital Expenditures
-----0-0
Free Cash Flow
-17.150.08-14.68-14.22-15.01-5.65
Free Cash Flow Growth
------

Margins
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Jun '25 Jun '24 Jun '23 Jun '22 Jun '21
Gross Margin
100.00%100.00%----
Operating Margin
126330.00%-7.21%----
Pretax Margin
134183.42%-5.35%----
Profit Margin
131387.00%-2.36%----
FCF Margin
129283.00%0.49%----

Valuation
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingAug '26 Jun '25 Jun '24 Jun '23 Jun '22 Jun '21
P/FCF Ratio
-181.89----
PS Ratio
-1556.150.90----